In this episode, Joe interviews founder and CEO of MindMed, JR Rahn. They discuss decriminalization, the DEA, ADHD, Xanax, and MindMed's goals: developing a trip-neutralizing drug and studying microdosing LSD for adult ADHD. <a class="" href= "http://www.psychedelicstoday.com/">www.psychedelicstoday.com</a> <p></p>

PTSF49 - MDMA For Alcoholism, The Placebo Effect, and Ceremonial Magicians

Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.